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Introduction {#sec1}
============

Cytotoxic T lymphocytes (CTLs) provide an important line of defense in the immune system, patrolling the body to seek out and destroy virally infected and cancerous cells. They do so with remarkable precision, leaving healthy cells unharmed as they recognize their targets. This is in large part due to a specific mechanism of polarized secretion directed by the centrosome, which docks at the point of contact on the plasma membrane ([@bib54]), focusing cytotoxic granules for release at the immunological synapse formed between a CTL and its target ([@bib52], [@bib53]). Secretion is tightly regulated and recent studies have revealed a critical role for the actin cytoskeleton in controlling both the initiation and termination of secretion ([@bib6], [@bib18], [@bib41], [@bib42]). However, it remains unclear how CTLs translate T cell receptor (TCR) signaling into rapid changes in the membrane, allowing for the tightly orchestrated secretion of granules during TCR activation.

Early imaging studies revealed that the first contacts between CTL and target occur via many small projections ([@bib23], [@bib46], [@bib47], [@bib48]) that extend from the front of migrating T cells ([@bib41]). Strikingly, the initial highly interdigitated interface between CTL and target rapidly flattens upon the initiation of TCR signaling to give an extended area of tight membrane contact as the immunological synapse forms ([@bib22]). These findings suggest that changes in the composition of the plasma membrane might underlie this transition in membrane structure and raise the possibility that membrane composition might be important for centrosome docking and granule delivery.

Phosphoinositides and other phospholipids play important roles in protein recruitment, signal transduction, and plasma membrane specialization in cells ([@bib10], [@bib57]). Phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) is the most abundant phosphoinositide, estimated to comprise ∼2% of the plasma membrane in lymphocytes ([@bib30], [@bib44]). The relative percentages of different phosphoinositides within the plasma membrane are controlled by a series of kinases and phosphatases ([Figure S1](#mmc1){ref-type="supplementary-material"}A; reviewed in [@bib2], [@bib26], [@bib34], [@bib36]). Regulating PI(4,5)P2 is particularly important as PI(4,5)P2 binds a variety of actin-regulating proteins and in this way regulates actin dynamics across the plasma membrane ([@bib10], [@bib21], [@bib37], [@bib40], [@bib43]). A number of observations support the idea that there are significant changes in the distribution of phosphoinositides and phospholipids in the plasma membrane as the synapse forms. First, TCR signaling triggers recruitment and activation of phospholipase Cγ1 (PLCγ1), which metabolizes PI(4,5)P2, generating diacylglycerol (DAG) that accumulates on the inner leaflet of the CTL plasma membrane in the synapse, playing an important role in centrosome polarization ([@bib38], [@bib51]). Second, PI(3,4,5)P3 becomes restricted to the periphery of the synapse in T cells ([@bib29]). Third, in keeping with the role of PI(4,5)P2 in recruitment of F-actin, the depletion of PI(4,5)P2 is accompanied by a loss of F-actin across the synapse prior to centrosome docking and cytolytic granule secretion ([@bib41], [@bib42]).

Centrosome docking at the plasma membrane is unusual in cells but is required for ciliogenesis. Recent reports have shown remarkable similarities between the mechanism of centrosome docking during ciliogenesis and immune synapse formation ([@bib54], [@bib56]). Membrane specialization has been reported in primary cilia, with PI(4,5)P2 and PI(3,4,5)P3 found only at the base of the cilium while PI(4)P is found in the ciliary body ([@bib8], [@bib13], [@bib33], [@bib35]). This raises the possibility that centrosome docking might be affected by membrane composition.

Our previous studies have revealed that TCR signaling leads to depletion of actin across the synapse, correlating with decreases in PI(4,5)P2 ([@bib41]). Given the importance of PI(4,5)P2 in both CTL function and ciliogenesis, we decided to examine the phosphoinositide composition as the immunological synapse forms and ask whether membrane specialization is required for centrosome docking and secretion at the immunological synapse. We find that TCR signaling triggers rapid changes in the phosphoinositide composition across the synapse, with cleavage of PI(4,5)P2 to DAG reducing not only actin recruitment but also the negative charge across the synapse. This change in membrane charge prevents phosphatidylinositol 4-phosphate 5-kinases type I (PIP5Ks) from associating with membranes. This in turn prevents replenishment of PI(4,5)P2 at the synapse, maintaining the level of actin depletion required for secretion. Thus, PIP5Ks act as molecular sensors of TCR activation, allowing localized secretion by controlling the membrane composition at the synapse.

Results {#sec2}
=======

PLCγ1 and DAG Accumulate while PI(4,5)P2 and Actin Are Depleted within the First 2 Min after CTLs Contact with Targets {#sec2.1}
----------------------------------------------------------------------------------------------------------------------

To follow changes in phosphoinositide composition as the immunological synapse forms, we used a panel of live-cell imaging probes capable of distinguishing the plasma membrane pool of phosphoinositides within the PI(4,5)P2 metabolic pathway ([Figure S1](#mmc1){ref-type="supplementary-material"}A), combined with 4D spinning-disc microscopy. In each case we co-expressed the F-actin probe, Lifeact-mApple or Lifeact-EGFP, which provides a biomarker for actin depletion during synapse formation ([@bib41]).

We imaged the initial steps of activation by expressing tagged PLCγ1, observed in the cytoplasm in CTLs ([Figure S1](#mmc1){ref-type="supplementary-material"}B), rapidly translocating to the plasma membrane of the synapse as F-actin (Lifeact-mApple) depleted across the synapse ([Figures 1](#fig1){ref-type="fig"}A--1C; [Videos S1](#mmc2){ref-type="supplementary-material"}A and S1B). PLCγ1, which associates with pLAT upon TCR activation ([@bib4], [@bib50]), is recruited to the plasma membrane both in LAT microclusters and independently of LAT ([@bib49]). We observed the initial accumulation of PLCγ1 at the synapse 48 s after first contact between CTL and target in the example shown, with small fluorescent puncta visible ([Figures 1](#fig1){ref-type="fig"}A and 1B). PLCγ1 accumulation expanded across the area of interaction as the initial depletion of actin was detected (1:36) (min:s) ([Figure 1](#fig1){ref-type="fig"}C). PLCγ1 intensity increased across the synapse as it formed and were sustained (∼60 units per pixel) until the peak of actin depletion (3:48), diminishing as actin recovered across the synapse (11:12); small puncta of PLCγ1 then re-appeared as CTLs dissociated from targets.Figure 1PLCγ1 and DAG Accumulate across the Synapse as It Forms(A--C) CTLs expressing PLCγ1-EGFP and Lifeact-mApple upon first contact with EL4-blue target (t = 0), initial clustering and depletion of probes with time (min:s); 83% conjugates, n = 24; 14 independent experiments.(A) Single confocal slices from [Video S1](#mmc2){ref-type="supplementary-material"}A shown as merged and separate channels.(B) En-face views across 3 μm slice of the synapse as single and merged channels with intensity plot for PLCγ1-EGFP.(C) Pixel intensity (y axis) plots against distance across the synapse (x axis, μm) for boxed region shown in (A).(D--F) CTLs expressing EGFP-PKCγ-C1 to detect DAG and Lifeact-mApple upon first contact between CTL and EL4-blue target (t = 0), initial accumulation and depletion of probes with time (min:s); 100% conjugates, n = 20; 10 independent experiments.(D) Single confocal slices from [Video S1](#mmc2){ref-type="supplementary-material"}B shown as merged and separate channels.(E) En-face views across 3 μm slice of the synapse as single and merged channels with intensity plot for DAG (EGFP-PKCγ-C1).(F) Pixel intensity (y axis) plots against distance across the synapse (x axis, μm) for boxed region shown in (D).Scale bars = 3 μm. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Video S1. Related to Figure 1. PLCγ1 Accumulates at the Synapse during Actin Depletion while DAG Accumulates at the Synapse during Actin DepletionVideo S1A corresponding to images in Figure 1A-C with PLCg1-EGP (green); Lifeact (red); targets (blue). Video S1B corresponding to images in Figure 1D-F with EGFP-PKCγ-C1 (DAG; green); Lifeact (red); targets (blue); scale bars = 3 μm.

As PLCγ1 generates diacylglycerol (DAG) by cleavage of PI(4,5)P2, we monitored the production of diacylglycerol (DAG) in the plasma membrane using the EGFP-PKCγ-C1 probe, which detects both the plasma membrane and nuclear pools of DAG. In unstimulated CTLs, only the nuclear pool of DAG was detected ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Upon target cell recognition, DAG accumulates at the synapse at 0:42 after initial contact in the example shown, when actin was enriched across the synapse ([Figures 1](#fig1){ref-type="fig"}D--1F; [Videos S1](#mmc2){ref-type="supplementary-material"}A and S1B). DAG accumulation increased as actin depletion began (0:56), distributing across the synapse as actin depleted (2:19) until DAG was no longer detectable by 4:24. The dynamics of PI(4,5)P2 and actin depletion across the synapse followed this same time course, with the depletion of both initially observed 1:20 after initial contact between CTL and target, peaking at 4:40 and recovering simultaneously at 8:27 in the example shown ([Figures 2](#fig2){ref-type="fig"}A--2C; [Video S2](#mmc3){ref-type="supplementary-material"}A). Line quantitation of pixel intensity across the synapse demonstrated how the dynamic loss of actin mirrors the loss of PI(4,5)P2 ([Figure 2](#fig2){ref-type="fig"}C).Figure 2The Immune Synapse Undergoes Membrane Specialization as It Forms(A--C) CTLs expressing EGFP-Tubby and Lifeact-mApple upon first contact with EL4-blue target (t = 0), initial depletion, and recovery of probes with time (min:s); 100% conjugates, n = 27; 14 independent experiments.(A) Single confocal slices from [Video S2](#mmc3){ref-type="supplementary-material"}A shown as merged and separate channels.(B) En-face views across 3 μm slice of the synapse as single and merged channels with intensity plot for PI(4,5,)P2 (Tubby).(C) Pixel intensity (y axis) plots against distance across the synapse (x axis, μm) for boxed region shown in (A).(D--F) CTLs expressing EGFP-tagged probes (as shown) and Lifeact-mApple upon first contact between CTL and EL4-blue target (t = 0), showing initial clustering and depletion of probes with time (min:s) taken from [Videos S2](#mmc3){ref-type="supplementary-material"}B--S2F.(D) Single confocal slices taken from [Video S2](#mmc3){ref-type="supplementary-material"}B (PA, PASS; 100% conjugates n = 9; all independent experiments), [Video S2](#mmc3){ref-type="supplementary-material"}C (PI(4)P, Osh2p-PHx2; 100% conjugates, n = 16; all independent experiments), [Video S2](#mmc3){ref-type="supplementary-material"}D (PS, Lactdherin-C2; 61% conjugates, n = 29; 14 independent experiments), [Video S2](#mmc3){ref-type="supplementary-material"}E (PI(3,4,5)P3, Grp1-PH; 100% conjugates, n = 27; 15 independent experiments), and [Video S2](#mmc3){ref-type="supplementary-material"}F (PI(3,4)P2, Bam32-PH; 70% conjugates, n = 10; all independent experiments) showing probes in green and Lifeact in red; EL4-blue targets in merged channel only.(E) Corresponding en-face views across 3 μm slice of the synapse as single and merged channels with intensity plot for the phosphoinositide probe.(F) En-Face Lifeact and phospholipid probe with pixel intensity plots of probes for boxed region shown in (D).See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Video S2. Related to Figure 2. PI(4,5)P2, PI(3,4,5)P3, PI(4)P and Actin Are Depleted from the Synapse Simultaneously while PI(3,4)P2 Increases and Phosphatidic Acid and Phosphatidylserine Are ConstantVideo S2A corresponding to images in Figure 2A-C with EGFP-Tubby (PI(4,5)P2; green). Video S2B corresponding to images in Figure 2D-F with EGFP-PASS (Phosphatidic acid/PtdOH; green). Video S2C corresponding to Figure 2D-F with EGFP-Osh2p-PHx2 (PI(4)P; green. Video S2D corresponding to Figure 2D-F with EGFP-Lactadherin-C2 (Phosphatidylserine; green). Video S2E corresponding to Figure 2D-F with EGFP-Grp1-PH (PI(3,4,5)P3; green). Video S2F corresponding to Figure 2D-F with EGFP-NES-Bam32-PH (PI(3,4)P2, green); in all videos Lifeact (red); targets (blue); scale bars = 3 μm.

By compiling the data from ≥13 videos for each combination of probes shown, we derived mean timings for these events ([Table S1](#mmc1){ref-type="supplementary-material"}). This analysis revealed that PLCγ1 first appeared at the plasma membrane 1:12 ± 11 s after CTL contact with the target, with DAG detected in the same time frame (58 ± 11 s), and the depletion of PI(4,5)P2 apparent at 1:56 ± 36 s together with the loss of F-actin (1:59 ± 22 s). Co-expression of probes for PLCγ1, DAG, PI(4,5)P2, and PI(3,4,5)P3 confirmed the co-ordinated changes in the phosphoinositides across the synapse with DAG accumulating and PI(4,5)P2 and PI(3,4,5)P3 (discussed below) depleting as PLCγ1 clustered at the synapse ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2D). These results show that dynamic changes in the phosphoinositide composition of the CTL plasma membrane occur within the first 2 min after cell contact as actin is reorganized across the forming synapse.

The Membrane across the Synapse Undergoes Specialization, with Reduction of PI(4)P, PI(4,5)P2, and PI(3,4,5)P3 and Accumulation of DAG and PI(3,4)P2 {#sec2.2}
----------------------------------------------------------------------------------------------------------------------------------------------------

The changes in PI(4,5)P2 and DAG seemed likely to affect other plasma membrane phosphoinositides as they lie in the same metabolic pathway ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Therefore, we examined changes in other phosphoinositides before ([Figures S1](#mmc1){ref-type="supplementary-material"}E--S1I) and after synapse formation at the point when actin was depleted ([Figures 2](#fig2){ref-type="fig"}D--2F; [Videos S2](#mmc3){ref-type="supplementary-material"}B--S2F). Phosphatidic acid (PA) was evenly distributed across the plasma membrane in CTLs and this distribution did not change upon interaction with target cells, when actin depleted across the synapse. Higher expression at the periphery of the synapse reflected membrane accumulation where CTL actin-rich lamellipodia grasped target cells (see PS images in [Figure 2](#fig2){ref-type="fig"}D). Phosphatidylinositol 4-phosphate (PI(4)P) diminished across the synapse as detected using the Osh2p probe ([Figures 2](#fig2){ref-type="fig"}D--2F) and was particularly clear when using the P4M probe ([Figure S2](#mmc1){ref-type="supplementary-material"}E; [@bib16]). In contrast, phosphatidylserine (PS) intensity was maintained at ∼100 units per pixel across the synapse when actin depleted ([Figures 2](#fig2){ref-type="fig"}D--2F). Thus, in most instances PA and PS content in the plasma membrane remained unchanged, while PI(4)P decreased together with PI(4,5)P2 as the synapse formed.

We asked whether there was any change in PI(3,4,5)P3 across the synapse in response to PI(4,5)P2 depletion and whether this also affected PI(3,4)P2 and PI(3)P ([Figures 2](#fig2){ref-type="fig"}D--2F, [S2](#mmc1){ref-type="supplementary-material"}D, and S2F). Using the Grp1-PH probe, which distinguishes PI(3,4,5)P3 from PI(3,4)P2 (while Akt-PH does not) ([@bib59]), we confirmed the depletion of PI(3,4,5)P3 across the synapse ([@bib29]); we were also able to show that this change coincided with depletion of actin across the synapse ([Figures 2](#fig2){ref-type="fig"}D--2F). Although the initial binding of the Grp1-PH domain may require interaction with PS in the membrane prior to specific binding to PI(3,4,5)P3 ([@bib28]), our finding that PS remained across the synapse suggests that PS is not playing a role in the differential distribution of Grp1-PH, which thus serves as a true reflection of PI(3,4,5)P3 distribution.

As PI(3,4)P2 is a product of SHIP1 action on PI(3,4,5)P3 (see [Figure S1](#mmc1){ref-type="supplementary-material"}A), we asked whether the depletion of PI(3,4,5)P3 affected PI(3,4)P2 across the synapse using the Bam32 probe ([Figure S1](#mmc1){ref-type="supplementary-material"}A). This revealed that PI(3,4)P2 concentrated at the synapse membrane as actin depleted ([Figures 2](#fig2){ref-type="fig"}D--2F), consistent with a role for SHIP1 in the depletion of PI(3,4,5)P3. No changes in PI(3)P were detected at the plasma membrane, with PI(3)P localized on intracellular vesicles both before and after synapse formation ([Figure S2](#mmc1){ref-type="supplementary-material"}F). These vesicles were LAMP1 deficient and did not polarize toward the synapse.

Taken together, these results show that there is a rapid change in membrane composition following the initial hydrolysis of PI(4,5)P2 to DAG by PLCγ1. This results in the formation of an area of membrane that is enriched in DAG and PI(3,4)P2 and depleted in PI(4,5)P2, PI(3,4,5)P3, and PI(4)P, with PA and PS not significantly changed ([Figure S2](#mmc1){ref-type="supplementary-material"}G).

PIP5 Kinase Distribution Changes as the Immune Synapse Forms {#sec2.3}
------------------------------------------------------------

The membrane specialization we observed across the immune synapse bore striking similarities to the phosphoinositide composition in primary cilia which, like the immune synapse, are focal centers for signaling, secretion, and endocytosis, with PI(4,5)P2 and PI(3,4,5)P3 depleted across both. This led us to ask whether similar mechanisms controlled membrane composition during both ciliogenesis and immune synapse formation. The phosphatase Inpp5e is required for membrane specialization during ciliogenesis ([@bib8], [@bib13], [@bib33], [@bib35]). As the balance of PI(4,5)P2 with PI(4)P can be regulated not only by Inpp5e but also the phosphatase OCRL1 and the three isoforms of PIP5K, α, β, and γ ([Figure S1](#mmc1){ref-type="supplementary-material"}A; [@bib15], [@bib27]), we asked whether any of these enzymes might play a role in the regulation of PI(4,5)P2 and actin and thereby control secretion from CTLs.

Overexpression of the phosphatases Inpp5e, OCRL1 A, or OCRL1 B with Lifeact-mApple revealed a broad cytoplasmic localization and some co-localization with Arf1, consistent with a concentration of both of these phosphatases on the Golgi apparatus ([Figure S3](#mmc1){ref-type="supplementary-material"}). However, there was little overlap with F-actin localization at the plasma membrane. In contrast, all three PIP5K proteins (α, β, and γ, all of which are expressed in CTLs) not only localized to the plasma membrane but also depleted across the synapse together with F-actin, suggesting a potential role in regulating PI(4,5)P2 across the synapse ([Figures 3](#fig3){ref-type="fig"}A--3E; [Videos S3](#mmc4){ref-type="supplementary-material"}A--S3C). We mapped the time course of PIP5Kβ using live imaging. In the example shown, the initial depletion of PIP5Kβ at 2:00 slightly preceded actin depletion at 2:13 when viewed en-face ([Figure 3](#fig3){ref-type="fig"}B). The pixel intensity plots show that actin depletion peaked at the same time as PIP5Kβ depletion at 8:26 ([Figure 3](#fig3){ref-type="fig"}C). Analyzing videos from 22 independent CTL-target cell conjugates gave mean values of 1:39 ± 10 s for the initiation of PIP5K depletion, with actin depleting almost simultaneously at 1:46 ± 11 s and recovering at 8:30 ± 41 s ([Table S1](#mmc1){ref-type="supplementary-material"}).Figure 3PIP5Kα, PIP5Kβ, and PIP5Kγ Dissociate as Membrane Charge Changes across the Synapse(A) CTL expressing PIP5Kβ-EGFP and Lifeact-mApple upon first contact with EL4-blue target (t = 0), depletion of probes and recovery with time (min:s). Images are single confocal slices from [Video S3](#mmc4){ref-type="supplementary-material"}A shown as merged and separate channels; 100% conjugates, n = 9, all independent experiments.(B) En-face views across 3 μm slice of the synapse as single and merged channels with intensity plot for PIP5Kβ-EGFP.(C) Pixel intensity (y axis) plots against distance across the synapse (x axis, μm).(D and E) CTLs expressing (D) EGFP-PIP5Kα or (E) mCherry-PIP5Kγ (green) and Lifeact-EGFP (red) synapsed with EL4-blue target cells (blue). Images show single confocal slices or en-face images as merged and separate channels from [Video S3](#mmc4){ref-type="supplementary-material"}B (PIP5Kα; 100% conjugates, n = 11, all independent experiments) and [Video S3](#mmc4){ref-type="supplementary-material"}C (PIP5Kγ; 100% conjugates, n = 9, all independent experiments), with an intensity plot for actin and PIP5Ks.Scale bars = 3 μm. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Video S3. Related to Figure 3. PIP5Kβ, PIP5Kα, and PIP5Kγ Are Depleted as Actin Relaxes at the SynapseVideo S3A corresponding to Figure 3A with PIP5Kβ-EGFP (green). Video S3B corresponding to Figure 3A with EGFP-PIP5Kα (green). Video S3C corresponding to Figure 3A with mCherry-PIP5Kγ (green) in all videos CTL express Lifeact (red); targets express Farnesyl-5-TagBFP2 (blue); scale bars = 3 μm.

PIP5Ks Regulate Actin Recruitment at the Immunological Synapse {#sec2.4}
--------------------------------------------------------------

Given the coincidence between the depletion of PIP5Ks and actin across the synapse, we asked whether PIP5Ks might play a role in the recruitment of actin to the synapse. We used a plasma membrane localization motif that would retain PIP5Ks across the synapse, by tagging PIP5Kβ-EGFP with the N-terminal Lyn-palmitoylation domain (MGCIKSKRKD) ([@bib19]). This generated a construct, which we named mPIP5Kβ in which the kinase was active, as well as a kinase-inactive form with a point mutation at K138 (mPIP5Kβ-K138A). Expression of these constructs resulted in plasma membrane localization of PIP5K that persisted at the interface between CTLs and targets ([Figures 4](#fig4){ref-type="fig"}A and 4B; [Videos S4](#mmc5){ref-type="supplementary-material"}A and S4C). Strikingly, CTLs expressing mPIP5Kβ were often rounded with only 14% (n = 106) showing any F-actin depletion across the synapse ([Figure 4](#fig4){ref-type="fig"}C). In contrast, CTLs expressing the kinase-dead mutation showed a typical polarized morphology with 76% (n = 96) showing depleted actin across the synapse ([Figure 4](#fig4){ref-type="fig"}C). These results show that altered localization of PIP5K is sufficient to modulate actin depletion across the synapse and this is dependent on its kinase activity.Figure 4Forced Localization of PIP5K to the Synapse Disrupts Actin Depletion, Centrosome Docking, and Secretion(A) Single confocal slices of CTLs expressing Lifeact-mApple (red) and mPIP5Kβ (green) from [Video S4](#mmc5){ref-type="supplementary-material"}A (representative of all 16 conjugates analyzed, all independent experiments) and (B) kinase-dead mPIP5Kβ-K138A (green) with EL4-blue target cells (blue) from [Video S4](#mmc5){ref-type="supplementary-material"}B.(C) CTLs expressing mPIP5Kβ or mPIP5Kβ-K138A (both green) synapsed with EL4-blue target cells (blue), fixed and stained with Phalloidin-Alexa555 (red) and mouse anti-acetylated tubulin (white), showing single confocal slices from separate channels and merged images. Scale bars = 3 μm.(D) Quantitation of CTLs with actin depletion across the synapse for samples shown in (C).(E) Distance of centrosome to target cell membrane, measured from the center of the acetylated tubulin intensity to the EL4 membrane in CTLs expressing mPIP5Kβ or mPIP5Kβ-K138A (n = 106 and 96, respectively, 3 independent experiments).See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Video S4. Related to Figure 4. mPIP5Kβ Blocks Actin Depletion across the Synapse while the Inactive Mutant mPIP5Kβ-K138A Does NotVideo S4A corresponding to Figure 4A with mPIP5Kβ (green). Video S4B corresponding to Figure 4B with mPIP5Kβ-K138A (green) in both videos cells are also expressing Lifeact (red) and targets are expressing Farnesyl-5-TagBFP2 (blue); scale bars = 3 μm.

Forced Localization of PIP5K to the Synapse Disrupts Centrosome Docking and Secretion {#sec2.5}
-------------------------------------------------------------------------------------

We next asked whether, by controlling changes in the membrane composition across the synapse, PIP5K also played a role in centrosome docking. Fixed CTL-target conjugates were co-stained with phalloidin to detect F-actin and antibodies against acetylated tubulin to identify the centrosome position. Measurement of the distance from the center of the highest concentration of acetylated tubulin to the synapse revealed that centrosome docking was impaired in CTLs expressing mPIP5Kβ, with only 7% docked (8/106) (\<0.5 μm); in contrast, CTLs expressing mPIP5Kβ-K138A in which the kinase is inactive showed efficient centrosome docking with 34% (31/92) docking at the synapse ([Figures 4](#fig4){ref-type="fig"}D and 4E). Thus, PIP5Ks have an important role in mediating the membrane changes required for efficient centrosome docking at the immune synapse.

We next asked whether granule secretion was impaired by forcing PIP5K to remain across the synapse. CTLs expressing mPIP5Kβ and mPIP5Kβ-K138A formed TCR-activated conjugates in which anti-pY demonstrated phosphorylation at the synapse ([Figure S4](#mmc1){ref-type="supplementary-material"}). We were further able to demonstrate that TCR signals were transduced, as activation gave rise to ERK phosphorylation in both mPIP5Kβ and mPIP5Kβ-K138A, as in CTLs expressing control farnesyl-EGFP ([Figure 5](#fig5){ref-type="fig"}A). We next asked whether secretion was impaired using a CD107a (Lamp1) degranulation assay ([Figure 5](#fig5){ref-type="fig"}B). In CTLs expressing mPIP5Kβ, there was no shift in CD107a signal upon TCR activation with OVA-pulsed targets compared to mPIP5Kβ-K138A-expressing controls, consistent with a defect in degranulation in CTLs expressing mPIP5Kβ ([Figure 5](#fig5){ref-type="fig"}B). We confirmed a loss of CTL cytotoxicity using an assay that measured target cell lysis via loss of a red nuclear marker expressed in target cells (NucRed EL4) ([Figure 5](#fig5){ref-type="fig"}C). This showed that while CTLs expressing mPIP5Kβ-K138A or the farnesyl-EGFP membrane marker triggered rapid target cell death, CTLs expressing the kinase active mPIP5Kβ failed to kill target cells. These results indicated that forced localization of PIP5K across the synapse disrupts granule secretion.Figure 5TCR Activation Fails to Induce Degranulation and Target Cell Killing(A) pERK activation of CTLs expressing mPIP5Kβ, mPIP5Kβ-K138A, or farnesyl-EGFP stimulated with plate-bound anti CD3 (black line) or unstimulated (shaded peaks) (n = 3 independent experiments).(B) Degranulation assay measured by CD107a uptake of CTLs expressing either mPIP5Kβ or mPIP5Kβ-K138A in response to targets pulsed with either OVA (bold line) or the null-peptide (NP68) (gray shaded peaks) after 2.5 hr (n = 4 independent experiments).(C) Percentage target cell lysis of NucRed-EL4 over 4 hr by CTL expressing either mPIP5K (dotted-line), mPIP5Kβ-K138A (gray line) or farnesyl-EGFP (black line) (showing propagated SEM of triplicates; n = 3 independent experiments).See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

PIP5Kα, PIP5Kβ, and PIP5Kγ Are Displaced as Membrane Charge Changes across the Synapse {#sec2.6}
--------------------------------------------------------------------------------------

Given the importance of the redistribution of PIP5Ks across the synapse, we sought to understand the mechanisms controlling membrane localization of PIP5Ks in CTLs. Many different mechanisms have been proposed to regulate PIP5K localization at the plasma membrane based on the ability of PIP5Ks to associate directly with Rac1, ARF6, AP-2, β-arrestin, talin, dishevelled, PA, and PI(4)P ([@bib27], [@bib58]). Studies in macrophages have shown that PIP5K localization can be dictated by membrane charge, with key positively charged amino acids in the activation loop of PIP5K interacting with negatively charged lipid head groups to stabilize PIP5K localization at the membrane ([@bib12], [@bib31]).

As the changes in phosphoinositides that we had observed seemed likely to alter membrane charge (cleavage of PI(4,5)P2 to generate DAG removes three negatively charged phosphate groups), we used a Kras+8 probe that binds to negatively charged membranes ([@bib60]) to detect changes in charge as the synapse forms ([Figures 6](#fig6){ref-type="fig"}A--6C; [Videos S5](#mmc6){ref-type="supplementary-material"}A--S5C). Strikingly, the Kras+8 probe associated with the plasma membrane in CTLs but was depleted in concert with actin as the synapse formed, with the pixel intensity plots for Kras8+ and actin closely matching ([Figures 6](#fig6){ref-type="fig"}B and 6C; 100% conjugates, n = 15; 8 independent experiments). Analysis of 15 CTLs provided mean times of 1:56 ± 42 s to the initial loss of binding of the charge probe, with actin depletion observed at 2:14 ± 33 s ([Table S1](#mmc1){ref-type="supplementary-material"}).Figure 6Membrane Charge Regulated PIP5K Distribution in the Synapse(A) CTLs expressing Lifeact-mApple with Kras+8 probe that binds negatively charged areas of the plasma membrane. Upon first contact between CTL and EL4-blue target (t = 0), depletion of probes and recovery with time (min:s). Images are single confocal slices from [Video S5](#mmc6){ref-type="supplementary-material"}A shown as merged and separate channels.(B) En-face views across 3 μm slice of the synapse as single and merged channels with intensity plot for EGFP-Kras+8.(C) Pixel intensity (y axis) plots against distance across the synapse/contact site (x axis, μm).(D) Schematic of the modifications made to the active loop of PIP5Kβ-EGFP.(E) PIP5K β-EGFP KR_N and PIP5Kβ-EGFP KR_A (both green) during depletion of F-actin (red) at the synapse (100% conjugates, n = 10; all independent experiments). Images are single confocal planes taken from [Video S5](#mmc6){ref-type="supplementary-material"}B (PIP5K β KR_N), and [Video S5](#mmc6){ref-type="supplementary-material"}C (PIP5K β KR_A).Scale bars = 3 μm.

Video S5. Related to Figure 6. The Charge Sensor Kras+8 Dissociates from the Membrane during Synapse Formation and Charge Regulates PIP5K Association with the MembraneVideo S5A corresponding to Figure 3C with EGFP-Kras+8 (green). Video S5B corresponding to Figure 3D (left) with PIP5Kβ-KR_N-EGFP (green). Video S5C corresponding to Figure 3D (right) with PIP5Kβ-KR_A-EGFP (green) CTL also express Lifeact (red); targets express Farnesyl-5-TagBFP2 (blue); scale bars = 3 μm.

To ask whether electrostatic interactions between PIP5K and the plasma membrane might be responsible for these changes, we mutated the key charged arginine and lysine residues required for electrostatic membrane association of PIP5K to either alanine (A) or asparagine (N) ([@bib12], [@bib31]) and examined the localization at the synapse ([Figures 6](#fig6){ref-type="fig"}D and 6E; [Videos S5](#mmc6){ref-type="supplementary-material"}A--S5C). Both sets of mutations resulted in a redistribution of PIP5Kβ from the plasma membrane to the cytoplasm in CTLs ([Figure 6](#fig6){ref-type="fig"}E). In contrast, a mutation that destroys kinase activity (K138A) ([@bib20]) tested in all three PIP5Ks had no effect on membrane localization (data not shown). These results show that electrostatic charge plays a key role in PIP5K association with the plasma membrane in CTLs and reveals a mechanistic basis for the dissociation of PIP5K as electrostatic charge changes across the synapse.

PIPKs Regulate Membrane Changes across the Synapse {#sec2.7}
--------------------------------------------------

Compiling our data from multiple videos using each of the probes, we were able to determine mean timings for the dynamic changes in membrane composition across the synapse as it formed ([Table S1](#mmc1){ref-type="supplementary-material"}; [Figure 7](#fig7){ref-type="fig"}). This revealed how highly co-ordinated these changes were, with DAG accumulation detected very rapidly after PLCγ1 first clusters at the synapse 1 min after CTL contact with the target. We noted that PLCγ1 often appeared initially as small vesicles forming a cluster before merging into a patch. While the resolution of our imaging for these videos cannot resolve the vesicles further, it is possible that this reflects the co-localization of PLCγ1 with LAT, which is vesicle associated ([@bib49]). While PLCγ1 remained across the synapse for an extended period, disappearing only after 12 min, the probe does not reveal how long the PLCγ1 remained in its active state.Figure 7Time Course of PIP5K Association at the SynapseDiagram of the average times (see [Table S1](#mmc1){ref-type="supplementary-material"}) of accumulation (PLCγ1 \[blue\] and DAG/PKCg-C1 domain \[green\]) or depletion (Tubby/PI(4,5)P2 \[yellow\], PIP5K \[magenta\], Kras+8/negative charge \[brown\], and Lifeact/F-actin \[red\]) with the probes subsequent loss or recovery during synapse formation (error bars represent SEM). See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Our results show that PI(4,5)P2 depletion, the decrease in negative charge, dissociation of PIP5Ks, and loss of F-actin across the synapse occur synchronously, initiating ∼2 min after CTL contact with a target and persisting for ∼2 min ([Figure 7](#fig7){ref-type="fig"}; [Table S1](#mmc1){ref-type="supplementary-material"}). These results support a model in which PIP5Ks and F-actin are associated with the plasma membrane. Upon TCR activation, PLCγ1 initiates cleavage of PI(4,5)P2 resulting in the appearance of DAG. The depletion of PI(4,5)P2 is accompanied by a loss of negative charge across this area of membrane, triggering dissociation of PIP5Ks from the membrane, preventing the replenishment of PI(4,5)P2. The PI(4,5)P2-dependent recruitment of actin across this membrane is also lost, allowing both centrosome docking and granule secretion to occur ([Figure S5](#mmc1){ref-type="supplementary-material"}). It is important to note that while PLCγ1 initiates the changes at the synapse, our data clearly show that without the dissociation of PIP5Ks, the membrane changes leading to actin depletion do not occur and neither centrosome docking nor secretion can occur. Our data identify PIP5Ks as sensors of TCR signaling, responding to a TCR-induced change in membrane charge and consequently controlling the membrane composition required for secretion in response to TCR signaling.

Discussion {#sec3}
==========

How TCR signaling is sensed and rapidly translated into changes that control granule secretion by CTLs is not understood. Although much is known about the changes in receptor and cytoskeletal organization at the synapse, relatively little is known about the corresponding changes in membrane composition and its importance in controlling centrosome docking and secretion. Recent findings have highlighted the role of PI(4,5)P2 in controlling transient actin depletion across the synapse, but the mechanisms controlling these changes have remained elusive. To investigate changes in membrane composition, we used a panel of bioprobes for phospholipids and their modulating lipases, kinases, and phosphatases to track membrane changes as the synapse forms. Within the first minute after CTL target recognition, PLCγ1 is recruited to the synapse, with the appearance of DAG and loss of PI(4,5)P2 and actin occurring within 2 min of contact. While PA and PI(3)P intensities appeared unchanged, PI(4)P, PI(4,5)P2, and PI(3,4,5)P3 decreased and PI(3,4)P2 increased across the synapse. Thus, a highly specialized domain of the plasma membrane is created rapidly as the synapse forms.

These initial changes in membrane composition result in a loss of negative charge across the CTL membrane, triggering dissociation of electrostatically associated PIP5Ks that otherwise would help to maintain this negative charge by generating PI(4,5)P2 from PI(4)P. This loss of PIP5Ks rapidly amplifies the initial PI(4,5)P2 depletion, driving actin dissociation and allowing granule secretion. We show that membrane association of PIP5Ks is charge dependent, as mutation of conserved positively charged amino acids prevented membrane association. However, by forcing continued PI(4,5)P2 generation across the synapse (using a charge-independent localization motif for PIP5Kβ), actin is maintained across the synapse, blocking centrosome docking and granule secretion upon TCR transduction. A reduced negative charge has also been observed in planar views of the Jurkat immune synapse using FLIM and FRET sensors, suggesting that this mechanism may also be used in CD4 T cells ([@bib32]).

We propose a model in which the initial cleavage of PI(4,5)P2 to DAG by TCR-activated PLCγ triggers the loss of membrane charge that is rapidly amplified by the subsequent loss of PIP5Ks ([Figure S5](#mmc1){ref-type="supplementary-material"}). Other mechanisms may also contribute to changes in membrane charge including DAG phosphorylation by diacylglycerol kinases (DGKs) to generate PA. However, DGKα is confined to the periphery of the synapse, thereby serving to limit DAG to the center of the synapse ([@bib7]). It is also possible that changes in PS, the most abundant anionic phospholipid in the membrane, might contribute to the loss of negative charge. Quantitation of PS across the synapse proved difficult with PS-rich intracellular organelles closely associated with the plasma membrane such that no clear change could be detected. During phagocytosis, PIP5Ks are displaced in response to a decrease in surface charge limiting local PI(4,5)P2 generation on the forming phagosome ([@bib12], [@bib17], [@bib31], [@bib61]). However, PS is maintained on the forming phagosome by PS delivery from endosomes ([@bib61]). A similar mechanism for regulating PS may also exist at the synapse, and the contribution of PS to the reduced membrane charge across the synapse remains unclear.

Our study highlights the importance of the dynamic PIP5K localization in controlling membrane changes in response to TCR activation. Previous studies have demonstrated the importance of actin dynamics in controlling granule secretion, with actin shown to deplete prior to granule release ([@bib5], [@bib18], [@bib39], [@bib41], [@bib42]) and to recover rapidly after degranulation ([@bib5], [@bib18], [@bib39], [@bib41], [@bib42]). Our studies support a role for PIP5Ks in regulating the actin dynamics controlling secretion from CTLs. Actin dynamics may contribute to CTL killing in other ways and it is tempting to speculate that not only the loss of actin but also the changes in phospholipid content of the membrane itself might cause the changes in membrane tension that facilitate CTL killing described in a previous study ([@bib3]).

Specialized domains of phosphoinositides are also observed during phagocytosis and play important roles in recruiting F-actin during formation and sealing of the phagosomal cup, controlled by modulation of PI(4,5)P2. Changes at the immune synapse appear to be a mirror image of those observed during phagocytosis. However, the specialization seen across the synapse is similar to that recently observed in primary cilia, with both PI(4,5)P2 and PI(3,4,5)P3 lost from the main body of the cilium ([@bib8], [@bib11], [@bib13]). As both centrosome docking at the synapse and ciliogenesis are disrupted when membrane composition is perturbed, this raises the possibility that membrane specialization might be required for successful centrosome docking in both contexts.

In conclusion, here we show how TCR signaling rapidly creates an area of plasma membrane specialization with a unique phosphoinositide composition and a reduced negative charge across the immune synapse, causing PIP5Ks to dissociate from the plasma membrane. Thus, PI(4,5)P2 depletion initiated upon TCR activation is perpetuated by the loss of PIP5Ks. The loss of PI(4,5)P2 and the consequent loss of F-actin polymerization facilitates centrosome docking and granule secretion in exact synchrony with TCR signaling, with PIP5Ks acting as sensors of TCR signaling, modifying the plasma membrane to facilitate granule secretion.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse monoclonal anti-acetylated tubulinSigma-AldrichCat \# T7451; RRID: [AB_609894](nif-antibody:AB_609894){#intref0010}Mouse Anti-Phosphotyrosine Platinum 4G10Merck/MilliporeCat\# 05-1050X; RRID:[AB_916370](nif-antibody:AB_916370){#intref0015}Alexa Fluor 647 donkey anti-mouse (H+L)Thermo Fisher scientificCat\# A-31571; RRID:[AB_162542](nif-antibody:AB_162542){#interref95}Alexa Fluor 405 goat anti-rabbit IgG (H+L)Thermo Fisher scientificCat\# A-31556; RRID:[AB_221605](nif-antibody:AB_221605){#interref100}Rat anti-CD107a PEThermo Fisher scientificCat\# 12-1071-82; RRID:[AB_657556](nif-antibody:AB_657556){#interref105}Rat anti CD16/CD32 (FcR blocking antibody)BiolegendCat\# 101301; RRID:[AB_312800](nif-antibody:AB_312800){#intref0025}Rat anti-CD8 Brilliant Violet 711BiolegendCat\# 100747; RRID:[AB_11219594](nif-antibody:AB_11219594){#intref0030}Hamster Anti-mouse CD3εBD BioscienceCat\# 550275; RRID:[AB_393572](nif-antibody:AB_393572){#intref0035}Rabbit anti-pErk1/2(T202/Y204) D13.14.4ECell Signaling TechnologyCat\# 4370; RRID:[AB_2315112](nif-antibody:AB_2315112){#interref110}Rabbit mAb IgG Isotype Control DA1ECell Signaling technologyCat\# 3900; RRID:[AB_1550038](nif-antibody:AB_1550038){#interref115}**Bacterial and Virus Strains**NEB 10-beta Competent *E. coli DH10B*New England BioLabsC3019**Chemicals, Peptides, and Recombinant Proteins**SIINFEKL (Ovalbumin peptide 257-264)AnaspecAS-60193-1ASNENMDAM (NP68 peptide 366-374)AnaspecAS-60623Recombinant mouse ICAM-1/CD45 Fc Chimera ProteinR&D Systems796-ICAlexa Fluor 555-PhalloidinInvitrogenA340554',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI)InvitrogenD130616% w/v paraformaldehydeElectron Microscopy Sciences15710 sBovine serum albumin (heat shock fractionation pH 7)Sigma AldrichA7906Prolong Diamond mounting mediumInvitrogenP36962PuromycinGIBCO/Thermo FisherA1113803Murine Interleukin 2 (IL-2)Peprotech212-12L-Glutamine 200 mMGIBCO25030-024Fetal bovine serum (FBS), heat inactivatedLabtechFCS-SAPenicillin/Streptomycin (P/S)Sigma-AldrichP0781DMEM (+ L-glutamine)GIBCO41966029CO~2~ independent medium (-L-Glutamine)GIBCO18045-054BamHIFermentas/Thermo FisherFD0054BshTIFermentas/Thermo FisherFD1464Eco91IFermentas/Thermo FisherFD0394HindIIIFermentas/Thermo FisherFD0504KpnIFermentas/Thermo FisherFD0524NheIFermentas/Thermo FisherFD0973SalIFermentas/Thermo FisherFD0644XhoIFermentas/Thermo FisherFD0694BsrGINew England BiolabsR0575KpnINew England BiolabsR0142**Experimental Models: Cell Lines**EL4-Farnesyl-5-TagBFP2 (EL4-blue)([@bib41])N/AEL4-NucLight-RedThis paperN/AEL4-MEM-iRFP670 (FR-EL4)This paperN/AEL4 ATCC TIB39ATCCATCC Cat\# TIB-39; RRID:CVCL_0255**Experimental Models: Organisms/Strains**B6.SVJ129-RAG1TM1BAL TG(TCRATCRB)1100MJBJAXCat\# JAX:003831, RRID:IMSR_JAX:003831**Recombinant DNA**EGFP-Lactadherin-C2S. Grinstein([@bib60])EGFP-Kras+8S. Grinstein([@bib60])EGFP-Grp1-PHC. Watts([@bib25])EGFP-FYVEx2H. Stenmark([@bib14])EGFP-OCRL1A/BM.Lowe([@bib9])mApple-Lifeact-7Addgene54747; RRID:[SCR_002037](rridsoftware:SCR_002037){#intref0040}mEGFP-Lifeact-7Addgene54610; RRID:[SCR_002037](rridsoftware:SCR_002037){#intref0045}mCherry-PIP5Kγ^661^Addgene29584; RRID:[SCR_002037](rridsoftware:SCR_002037){#intref0050}EGFP-P4M-SidMx2Addgene51472; RRID:[SCR_002037](rridsoftware:SCR_002037){#intref0055}EGFP-Osh2p-PHx2T.Balla([@bib55])EGFP-TubbyT.Balla([@bib55])mTagRFP-NEvrogenFP142EGFP-C1, N1 and mCherry-C1Takara Bio/Clontech6084-1, 6085-1 & 632524mPIP5K1β-EGFPThis paperGeneBank: P25911/P70181mPIP5K-K138A-EGFPThis paperGeneBank: P25911/P70181EGFP-NES-PASSThis PaperGeneBank: P63248/Q04359EGFP-NES-Bam32-PHThis paperGeneBank: P63248/Q9QXT1EGFP-PKCγ-C1 domainThis paperGeneBank: P63318EGFP-PIP5KαThis paperGeneBank: P70182PIP5Kβ-EGFPThis paperGeneBank: P70181PIP5Kβ-KR_A-EGFPThis paperGeneBank: P25911/P70181PIP5Kβ-KR_N-EGFPThis paperGeneBank: P25911/P70181EGFP-Inpp5eThis paperGeneBank: Q9JII1PLCγ1-EGFPThis paperGeneBank: Q62077PKAi-NES-PASS gBlockThis paperIntegrated DNA TechnologiesPKAi-NES-Bam32-PH gBlockThis paperIntegrated DNA TechnologiesPKCγ-C1 domain gBlockThis paperIntegrated DNA TechnologiesPIP5Kβ K_RA gBlockThis paperIntegrated DNA TechnologiesPIP5KβK_RN gBlockThis paperIntegrated DNA Technologies**Software and Algorithms**ImarisBitplaneRRID:[SCR_007370](rridsoftware:SCR_007370){#intref0060}Prism 5GraphpadRRID:[SCR_002798](rridsoftware:SCR_002798){#intref0065}IncuCyte Spheroid Software ModuleEssen BioScience, Sartorius9600-0019FlowJo software v10 and v9Flow Jo LLC treestarRRID:[SCR_008520](rridsoftware:SCR_008520){#intref0070}ImageJImageJ.netRRID:[SCR_003070](rridsoftware:SCR_003070){#intref0075}

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Professor Gillian M Griffiths (<gg305@cam.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

C57BL/6 OT-I^Rag1−/−^ mice (RRID:IMSR_JAX:003831) This research has been regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB).

Method Details {#sec4.4}
--------------

### Tissue culture and cell preparation {#sec4.4.1}

Splenocytes from C57BL/6 OT-I^Rag1−/−^ mice (RRID:IMSR_JAX:003831) were isolated by manual rupture of the spleen. Splenocytes were resuspended (∼10^8^ cells/mL) in culture media (RPMI, 10% FCS, 50 U/mL penicillin-streptomycin, 1 mM sodium pyruvate, 2mM L-glutamine, 50μM β2-mercaptoethanol, 100 U/mL IL-2) and incubated with 10 nM SIINFEKL peptide for 3 days at 37°C, 8% CO~2~, washed and cultured for a total of 5-10 days. EL4-MEM-iRFP670 were generated by transduction of EL4 with pMig-MEM-RFP670,. EL4-Farnesyl-5-TagBFP2 (EL4-blue) and EL4-MEM-iRFP670 (FR-EL4) target cells were maintained in DMEM, 2mM L-glutamine, 10% FBS (GIBCO), 50 U/mL pen/strep (EL4 media).

### RNA preparation, cDNA generation cloning and plasmids {#sec4.4.2}

cDNA was synthesized using oligo dT primers from RNA isolated from 5x10^6^ OT-I CTL (3-5 days post-activation) with the RNA mini (QIAGEN) and AffinityScript cDNA synthesis kits (Agilent technologies). PCR amplifications were carried out using AccuPrime Pfx DNA polymerase kits in a G-storm thermal cycler system 482 (G-storm Ltd, Labtech International). Site-directed mutagenesis used the QuickChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies); ligations, the Quick ligation kit (New England Biolabs). Synthesized double stranded DNA were designed then manufactured by Integrated DNA Technologies (gBlocks; IDT, Iowa, USA) and cloned into pSC-B carrier plasmids using the StrataClone Blunt PCR Cloning Kit (Agilent Technologies).

### Lipid probes {#sec4.4.3}

EGFP-Tubby was used to detect PI(4,5)P2. The C1-domains of PKCγ equivalent to amino acids (aa) 35-150 were made into a gBlock and cloned into EGFP-C1 (Clontech) at KpnI and BamHI sites to detect DAG. Likewise, a gBlock corresponding to the phosphatidic acid biosensor with superior sensitivity (PASS), derived from the yeast protein Spo20p phosphatidic acid binding domain (PABD) ([@bib62]) was also cloned into EGFP-C1 at restriction sites XhoI and SalI. Detection of PI(4)P was with Osh2p ([@bib45]). PS was detected with the C2 domain of Lactadherin ([@bib60]). Detection of PI(3,4,5)P3 used the specific Grp1-PH probe ([@bib24]). As both Bam32-PH and the TAPP1-PH domains available to detect PI(3,4)P2 showed strong nuclear localization ([@bib1], [@bib25]), we included the nuclear export signal (NES) of Protein Kinase A inhibitor aa 38-47 (LALKLAGLDI) before the Bam32-PH domain aa 164-256. NES-Bam32 was made into a gBlock and inserted into EGFP-C1 at restriction sites BsrGI and KpnI. This improved signal for the plasma membrane pool of PI(3,4)P2. PI(3)P was detected using EGFP-FYVEx2 ([@bib14]).

### Cell preparation for live cell microscopy {#sec4.4.4}

1 × 10^7^ OT-I CTLs (5--8 days after activation) were nucleofected 24 h prior to imaging with 5 μg Lifeact-mApple and probe construct plasmids using the Mouse T Cell Nucleofector Kit (Lonza). EL4-blue target cells were pulsed with 1 μM SIINFEKL for 30 min at 37°C, washed in serum-free CO~2~-independent medium (with L-glutamine) and plated onto 35-mm glass-bottom culture dishes (MatTek) coated with 0.5 μg/mL murine ICAM-1/Fc. ∼2 × 10^6^ nucleofected CTLs in CO~2~-independent T cell medium were added dropwise, imaging was started within 5 min. Interactions were imaged with cells in an environmental chamber maintained at 37°C (Okolabs) on an Olympus IX81 microscope (Olympus) using the Andor Revolution spinning-disc microscope with Yokogawa CSU-X1 spinning disk, iXon Ultra 888 EMCCD camera, 2x camera adaptor (Andor Technology, Oxford instruments) and Olympus Universal Plan Super Apochromat silicone immersion objective. 12-18 z stacks (0.8-μm apart) were imaged every 12 s with fluorophores excited at 405, 488, and 561 nm in each z-plane. 4D datasets were rendered and analyzed with Imaris software (Bitplane).

### Fixed cell preparation, image collection and quantitation {#sec4.4.5}

OT-I CTLs (2-6 days post-activation) were nucleofected with 5 μg DNA encoding wild-type mPIP5Kβ or mPIP5Kβ-K138A, mixed with peptide pulsed targets (as above) in serum-free, CO2-independent T cell media at 37°C for 5 min, plated onto glass coverslips (n = 1.5; VWR) and allowed to form conjugates for 20 min. Cells were fixed with 4% v/v paraformaldehyde at 37°C and washed at room temperature with PBS and quenched in Tris buffered saline (TBS) before permeabilization in TBS, 0.2% Triton X-100 (Sigma Aldrich) for 5 min. Samples were blocked with TBS, 2% BSA for 20 min before incubation with mouse anti-acetyl tubulin for 1h. Samples were washed in tris buffered saline and incubated with goat anti-mouse IgG-Alexa 647 and Phalloidin-Alexa fluor 555 for 30 min. Coverslips were washed, mounted with Prolong Diamond mounting medium and imaged on an Andor Revolution spinning-disc microscope (as above) with z stacks at 0.15 μm intervals.

### Intracellular Phospho-protein Flow Cytometry {#sec4.4.6}

Nucleofected cells were sorted for GFP expression, and stimulated with 2 μg/mL plate-bound anti-CD3ε antibody for 60 min at 37°C. Cells were fixed in 4% paraformaldehyde at room temperature for 15 min and washed in PBS. Pre-chilled cells were permeabilized with 90% ice-cold methanol for 30 min on ice. Cells were washed in PBS and resuspended in buffer (1% FBS in PBS) with 1 μg/mL FcR blocking antibody with either 2.5 μg/mL rabbit anti-pERK1/2 antibody or 12.5 μg/mL rabbit IgG isotype control antibody and incubated for 1h at room temperature. After washing in buffer, cells were resuspended in buffer containing 1 μg/mL FcR antibody and 10 μg/mL Alexa Fluor 405 goat-anti-rabbit incubated for 30 min at room temperature. Cells were washed in incubation buffer prior to data acquisition on a BD LSRFortessa (BD Biosciences). The data was analyzed with FlowJo (FlowJo, LLC).

### Degranulation assay {#sec4.4.7}

FR-EL4-were pulsed with 1 μM ovalbumin peptide (SIINFEKL) or control peptide NP68 (ASNENMDAM) for 1 hour at 37°C before washing to remove free peptide. 1x10^5^ CTLs were cultured 1:1 with pulsed FR-EL4 cells for 2.5 h in culture media supplemented with 2 μg/mL anti-CD107a PE in round-bottom 96-well plates. Cells were stained on ice with FCR antibody, DAPI, and anti-CD8 Brilliant Violet 711. Flow cytometry was performed on BD LSRFortessa (BD Biosciences) and data were analyzed in FlowJo.

### Cytotoxicity assay {#sec4.4.8}

EL4 cells expressing a non-perturbing red nuclear marker (NucLight-Red; Essen Bioscience, Sartorius) (NucRed EL4) were pulsed with 1 mM SIINFEKL peptide, washed and incubated with OT-I CTL expressing either mPIP5Kβ-EGFP or mPIP5Kβ-K138A-EGFP or farnesyl-EGFP. Triplicate samples of 20000 CTL were plated with 2000 EL4 cells per well. The assay was performed in an IncuCyte S3 live cell analysis system (Essen Bioscience, Sartorius) maintained at 37°C and 10% CO~2~. Cells were allowed to settle in the plates for 30 min and images were captured every 30 min over 4 h using the 565-605nm laser line and the 4x objective. Loss of NucRed EL4 intensity was quantitated using IncuCyte S3 software with the spheroid quantitation application. Data were exported and calculated as percentage of target cell loss based on the initial target cell number for each well analyzed then plotted using Prism software (Graphpad).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Cell choice {#sec4.5.1}

Nucleofected OT-I cells were added dropwise to dishes and allowed to settle for less than 5 min. After this point a systematic scan across the dish was undertaken until a cell that was double labeled (expressing both nucleofected plasmids) to detectable level and in close location to the target EL4 blue was selected for filming. In fixed samples a systematic scan was made from the top left of the coverslip to the right and images were taken at either 60 or 100x of the EGFP positive cells for quantitation measurements. Images were analyzed using Imaris software (Bitplane) line tool to determine centrosome-to-synapse distances and \> 5-fold depletion of the F-actin signal across the synapse relative to membrane outside the synapse.

### Quantitation in ImageJ/Fiji {#sec4.5.2}

Movies of CTL expressing lipid probes and Lifeact during synapse formation were analyzed using Imaris software. Single representative Z-planes within the projected images through the center of the synapse were captured as Tiff files, opened in ImageJ/Fiji (ImageJ open source software <http://Imagej.net>) and split into their respective red, green and blue channels. Pixel intensity values were determined across 2.1 μm depth as indicated in each figure to capture the undulating interface across each synapse. "Accumulation" is defined as pixel intensity \> pixel intensity at initial contact (t = 0); "peak" intensity as the highest pixel intensity value compared to t = 0 and "recovered" when pixel intensity values return to t = 0. Fold changes vary for different probes as shown in pixel intensity plots for each figure.

### Error {#sec4.5.3}

All error in graphs is standard error of the mean or propagated standard error of the mean where it is stated ([Figure 5](#fig5){ref-type="fig"}C)

Data and Software Availability {#sec4.6}
------------------------------

Due to the size of the raw dataset it will be made available on request.
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